2-165354232-G-T
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001040142.2(SCN2A):c.2960G>T(p.Ser987Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S987C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001040142.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- developmental and epileptic encephalopathy, 11Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- episodic ataxia, type 9Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- benign familial neonatal-infantile seizuresInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- malignant migrating partial seizures of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN2A | ENST00000375437.7 | c.2960G>T | p.Ser987Ile | missense_variant | Exon 17 of 27 | 5 | NM_001040142.2 | ENSP00000364586.2 | ||
| SCN2A | ENST00000631182.3 | c.2960G>T | p.Ser987Ile | missense_variant | Exon 17 of 27 | 5 | NM_001371246.1 | ENSP00000486885.1 | ||
| SCN2A | ENST00000283256.10 | c.2960G>T | p.Ser987Ile | missense_variant | Exon 17 of 27 | 1 | ENSP00000283256.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 11 Pathogenic:1
Inborn genetic diseases Pathogenic:1
The p.S987I variant (also known as c.2960G>T), located in coding exon 16 of the SCN2A gene, results from a G to T substitution at nucleotide position 2960. The serine at codon 987 is replaced by isoleucine, an amino acid with dissimilar properties. This alteration has been detected as a de novo occurrence in an individual with early infantile epileptic encephalopathy (EIEE) (Trump N et al. J. Med. Genet., 2016 May;53:310-7) and was also detected in an individual with epilepsy, vertigo, and episodic ataxia (Fokstuen S et al. Hum. Genomics, 2016 Jun;10:24). In addition, this variant lies buried a domain and is more disruptive than known nearby pathogenic variants (Ambry internal data; Berman HM; Acta Crystallogr. D Biol. Crystallogr. 2002 Jun;58). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Seizure;C0042571:Vertigo;C1720189:Hereditary episodic ataxia Pathogenic:1
not provided Pathogenic:1
The Ser987Ile missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Project has not identified Ser987Ile in approximately 6,500 individuals of European or African American ethnicity, indicating that it is not a common benign variant in these populations. The amino acid substitution is non-conservative, as a polar Serine residue is replaced by a non-polar Isoleucine residue. The Ser987Ile substitution alters a highly conserved position in the intracellular loop between the second and third transmembrane domains, and other mutations in this region of the protein have been reported in association with benign familial neonatal-infantile seizures (Shi et al., 2012). Additionally, several in silico algorithms predict Ser987Ile is damaging to protein structure/function. Therefore, Ser987Ile is a strong candidate for a disease-causing mutation. The variant is found in EPILEPSY,INFANT-EPI panel(s).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at